Drug or treatment

Bexmarilimab clinical trials

As of November 12, 2026, Find a Trial lists 3 clinical trials of Bexmarilimab that are recruiting, at sites in 8 countries (most in United Kingdom (2), Spain (1), Czechia (1)). By phase: Phase 1/2 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Bexmarilimab plus nivolumab in solid tumors, melanoma, and NSCLC Phase 1/2 Manchester and 1 other locations Recruiting Jul 21, 2026
Bexmarilimab with Azacitidine vs Placebo with Azacitidine in Adults with Higher-Risk MDS Phase 2 Duarte, California and 34 other locations Recruiting Jun 29, 2026
Bexmarilimab with doxorubicin for metastatic soft-tissue sarcoma Phase 1/2 Badalona and 10 other locations Recruiting Mar 10, 2026

All recruiting trials (3)

Quick answers

How many clinical trials of Bexmarilimab are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 8 countries. The most sites are in United Kingdom (2 trials), Spain (1 trial), Czechia (1 trial), Finland (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.